Infinity Pharmaceuticals, Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fab3bfcc-0d7b-4eab-bafc-456c3f8c1e88/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $2.6M | 2022-01-01 – 2022-12-31 | evidence 0001113148-23-000003 |
| FY 2021 | $1.9M | 2021-01-01 – 2021-12-31 | evidence 0001113148-22-000007 |
| FY 2020 | $1.7M | 2020-01-01 – 2020-12-31 | evidence 0001113148-21-000007 |
| FY 2019 | $3.0M | 2019-01-01 – 2019-12-31 | evidence 0001113148-20-000004 |
| FY 2018 | $22.1M | 2018-01-01 – 2018-12-31 | evidence 0001113148-19-000002 |
| FY 2017 | $6.0M | 2017-01-01 – 2017-12-31 | evidence 0001113148-19-000002 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Infinity Pharmaceuticals, Inc. — all facts · Net Income · Operating Income